enGene Holdings Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.4% | +192.8% | -2.4% | +16.6% | -8.1% | -6.7% | -7.9% | -9.8% | +52.2% | -8.8% | -6.2% | |
| – | +4.8% | +201.0% | -2.6% | -5.8% | -10.1% | +2.5% | -7.3% | -4.7% | +43.6% | -6.6% | +2.9% | |
| – | +5.1% | +209.2% | -2.7% | -32.9% | -64.0% | -7.7% | -43.3% | +53.7% | -27.0% | -18.5% | +37.5% | |
| – | +5.2% | +209.0% | -2.7% | -7.5% | -10.3% | +1.7% | -7.1% | -4.0% | +42.4% | -6.3% | +3.0% | |
| – | -51.8% | +7.3% | -80.1% | +328.2% | -58.3% | +24.0% | +33.0% | +214.1% | -46.3% | +144.1% | -1.6% | |
| – | +3.9% | -5.1% | +0.0% | – | – | – | – | – | – | – | – | |
| – | +114.4% | -1.5% | +19.6% | +5.5% | -6.7% | +9.4% | +14.0% | +19.8% | +3.4% | -5.8% | +10.8% | |
| – | +31.3% | -8.8% | +113.7% | +8.9% | -11.6% | +39.0% | +13.5% | +56.5% | -23.0% | -12.7% | +26.6% | |
| – | -30.1% | +7.1% | +318.8% | -36.4% | +87.7% | +90.0% | +73.4% | +44.3% | -75.0% | -1.0% | -1.3% | |
| – | +10.3% | -83.5% | +1,256.4% | -50.7% | +84.6% | -39.8% | +52.1% | +180.5% | -63.6% | -26.4% | +41.7% | |
| – | +0.0% | +0.9% | -4.9% | +4.0% | -3.5% | -7.7% | -11.6% | -13.5% | +61.4% | +0.7% | +1.0% | |
| – | -13.9% | +289.5% | -5.2% | +18.4% | -8.3% | -9.1% | -11.7% | -16.4% | +67.9% | -9.4% | -9.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -25.9% | +70.0% | +12.0% | +2.1% | +13.0% | +0.1% | +0.2% | +0.4% | +31.1% | +3.7% | +0.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.